Dr. Andrew Chan, Chief of Clinical and Translational Epidemiology Unit at Massachusetts General Hospital discusses the presentation from Digestive Disease Week® titled “Physical activity is associated with a lower risk of esophageal cancer”.
Dr. Keyan Salari, a urologic oncologist at Massachusetts General Hospital and instructor in surgery, Harvard Medical School discusses his Abstract presentation from the American Urological Association (AUA2020) Annual Meeting titled “5-alpha reductase inhibitors and risk of overall and fatal bladder cancer”.
Returning guest, award-winning author, speaker, and international health advocate Silvie Beljanski discusses several tips on strengthening immunity and obtaining wellness balance. She talks about how she views COVID-19 as an environmental toxin, how the war on cancer is impacted by the focus and resources applied to COVID-19, and what we need to know about integrative medicine when considering experimental COVID drug treatments.
Dr. Raymond Liu, MD, discusses a new research paper that details how Kaiser Permanente Northern California (KPNC) quickly ramped up its existing telehealth oncology program at the onset of the COVID-19 pandemic. The paper published in JCO Oncology Practice, titled “Telehealth in Oncology During the COVID19 Outbreak: Bringing the house call back virtually,” offers insights for medical centers and health systems throughout the country that are facing similar challenges.
Dr. Jacob Sands, a thoracic medical oncologist at the Dana-Farber Cancer Institute and Instructor of Medicine, Harvard Medical School, discusses advanced lung cancer and a new initiative by Merck in collaboration with the GO2 Foundation for Lung Cancer called “Worth the Fight: Taking on Lung Cancer”, that offers support and resources to people impacted by advanced lung cancer and empower them to take an active role in their cancer care.
Returning guest, Ken Cahill, CEO of SilverCloud Health, discusses how they are responding to the coronavirus pandemic with the increased demand for effective mental health treatment. SilverCloud offers an industry-leading, clinically-validated digital mental health platform used by over 300 organizations around the world including Optum Health and 70% of the UK’s NHS.
Dr. Michael Dougan, gastroenterologist/internist at Massachusetts General Hospital discusses the research presented at Digestive Disease Week® (DDW) 2020 titled “Immune checkpoint inhibitor-associated celiac disease”.
Dr. Zoe Memel, MD, PG1, Department of Medicine, Massachusetts General Hospital discusses the research presented at Digestive Disease Week® (DDW) 2020 titled “Aspirin use is associated with a reduced incidence of hepatocellular carcinoma: a systematic review and meta-analysis”
Dr. Eric A. Klein, Chairman of the Glickman Urological & Kidney Institute and a staff member in the Taussig Cancer Institute at Cleveland Clinic, discusses prostate cancer research released at the American Urological Association (AUA) 2020 meeting demonstrating the positive impact of the Oncotype DX Genomic Prostate Score® (GPS™) test to help make treatment decisions in African-American men with clinically localized prostate cancer. He was also author on the abstract titled “A 17-Gene Genomic Assay as a Predictor of Outcomes in African Americans with Prostate Cancer” presented at AUA.
Dr. Robert Giugliano, MD, discusses data released from the FOURIER study, an analysis evaluating patient-reported cognition in high-risk heart disease patients, including patients achieving low levels of LDL-cholesterol after an average of two years of treatment. The data were published in the “Journal of the American College of Cardiology” May 2020